156 TISSUE INHIBITOR OF METALLOPROTEINASES-3 INDUCTION BY TRANSFORMING GROWTH FACTOR BETA IN HUMAN CHONDROCYTES IS MEDIATED BY SMAD SIGNALING  by Qureshi, H. et al.
C94 Poster Presentations
kinase 2 (MK2) is one of several serine/threonine kinases down-
stream of p38 signalling and has been reported to mediate the
post-transcriptional regulation of TNF-α. However, at present,
little is known about the functional role of MK2 in mediating
the effects of p38 activation in human cells. In this study we
examined the role of MK2 in mediating the cellular response
to pro-inﬂammatory cytokines in human cells including primary
osteoarthritic (OA) chondrocytes
Methods: Primary chondrocytes were isolated by collagenase
digestion of cartilage from the knee joints of OA patients following
joint replacement surgery and cultured in monolayer. Transfec-
tion with MK2 siRNA or a non-targeting control siRNA (Applied
Biosystems) was achieved using lipid (Atugen). Gene expres-
sion was determined by Real time-PCR using Taqman probes.
Production of prostaglandin E2 (PGE2), and of matrixmetallopro-
teases 3 (MMP3) and MMP13 (collagenase 3) were measured
by ELISA
Results: We found that both TNF-α and IL-1 were capable of
inducing the phosphorylation of HSP27 (an MK2 substrate) in
HeLa cells and that this phosphorylation was inhibited by over-
expression of a dominant-negative form of MK2. Furthermore,
over-expression of this dominant negative form of MK2 signiﬁ-
cantly reduced the IL-1 and TNF-α mediated release of PGE2
over a 24h period (P<0.05). To investigate this further we ex-
amined the role of MK2 in isolated primary OA chondrocytes
from human OA knee joints. Transfection of siRNA antisense
resulted in a reduction in OA chondrocyte MK2 mRNA by 95%
after 48h, and a corresponding reduction of MK2 protein 72h
post-transfection. Transfection of OA chondrocytes with MK2
siRNA also reduced both basal PGE2 release (P<0.05) and
IL-1-induced PGE2 release (P<0.01). Importantly, we also found
that siRNA-induced knockdown of MK2 signiﬁcantly reduced both
basal and IL-1-induced MMP13 mRNA expression (P<0.01) and
IL-1 induced MMP13 and MMP3 protein release (P<0.05).
Conclusions: Our data reveal that MK2 is required for PGE2,
MMP3 and MMP13 release from OA chondrocytes. These ﬁnd-
ings suggest a role for MK2 in contributing to OA algesia and
OA joint structural deterioration by mediating the downstream
effects of p38 activation on PGE2 release and the expression
and release of catabolic proteases.
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PI3K REGULATES CHONDROCYTE DIFFERENTIATION
V. Ulici, K.D. Hoenselaar, F. Beier
University Of Western Ontario, London, ON, Canada
Purpose: Endochondral ossiﬁcation, the process through which
long bones are formed, involves chondrocyte proliferation and
hypertrophic differentiation in the cartilage growth plate. These
processes are often recapitulated during osteoarthritis. Numer-
ous growth factors and hormones have been implicated in the
regulation of growth plate biology, however, less is known about
the intracellular signaling pathways involved. The purpose of our
study was to characterize the involvement of PI3K/Akt signaling
in cartilage development. We focused on the PI3K/Akt pathway
since is known as a major regulator of cellular proliferation,
differentiation and death in multiple cell types.
Methods: Employing an organ culture system of embryonic
mouse tibias and LY294002, a pharmacological inhibitor of PI3K
we compared the length of the tibiae, different zones of the
growth plate, between LY294002 treated bones and the con-
trol. Immunohistochemistry assays with antibodies for collagen
X, p57 and phosphorylated Akt were performed on sections
obtained from the two treatments. We then performed similar
experiments using long bones from Akt1 (main target of the
PI3K) KO and control mice. Using micro CT analysis, skeletons
of Akt1 KO and control mice were compared. Primary chondro-
cytes were isolated from long bones of E15.5 mouse embryos
and were treated with LY294002 or control for a few days, then
TUNEL staining for apoptosis and cell counts were performed.
RNA was isolated from primary chondrocytes after 24 hours of
culture in the presence of LY294002 or DMSO and hybridized to
Affymetrix gene chips. Pathways and functional categories regu-
lated by PI3K signaling were then identiﬁed using Bioinformatics
approaches.
Results: PI3K inhibition results in smaller proliferative and hy-
pertrophic zones of the growth plate, reduced area of p57 stain
and decreased cell numbers in primarychondrocyte cultures, in-
dicating that this pathway is required for maximal proliferation
and differentiation. TUNEL staining of primary chondrocytes also
showed an increased number of apoptotic cells in LY294002
treated cultures compared to controls.
From birth until adulthood, Akt1 KO mice are smaller than their
littermates and most of their long bones are 10% shorter than
in wild-type littermates. KO bones also show delayed growth
plate development (as shown by micro-CT) as well as delayed
formation of secondary ossiﬁcation centers. Similar to LY29400-
treated organ cultures, growth plates from Akt1-deﬁcient mice
display reduced length of hypertrophic zone. Microarray analyses
coupled to bioinformatics identiﬁed numerous target genes of
PI3K activity in chondrocytes as well as functional categories
controlled by this signaling pathway.
Conclusions: In summary, our data demonstrate an essential
role of PI3K signaling in endochondral bone growth and provide
insight into the involved molecular mechanisms.
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TISSUE INHIBITOR OF METALLOPROTEINASES-3
INDUCTION BY TRANSFORMING GROWTH FACTOR
BETA IN HUMAN CHONDROCYTES IS MEDIATED BY
SMAD SIGNALING
H. Qureshi, G. Ricci, M. Zafarullah
University of Montreal, Montreal, PQ, Canada
Purpose: To study the role of Smad signaling pathway in
transforming growth factor beta induction of Tissue inhibitor of
metalloproteinases-3 (TIMP-3).
Methods: Normal human knee chondrocytes (Cambrex, Walk-
erville, MD) were grown in Differentiation Bullekit medium as
high-density short-term monolayer cultures. Cells were either
treated with various pharmacological inhibitors or tranfected with
negative control or Smad-speciﬁc siRNAs. Subsequently, cells
were stimulated with TGF-β. Knockdown of respective proteins
and effect on TIMP-3 was studied by Western blot analysis. Pro-
moter and deletion mutants were constructed and transfected
by a high-efﬁciency, modiﬁed Calcium phosphate method. Lu-
ciferase assays were also conducted to monitor the promoter
activity.
Results: TGF-β1-enhanced Smad2 phosphorylation and TIMP-3
protein expression could be inhibited by the Smad2/3 phosphory-
lation inhibitors, PD169316 and SB2023580 but not by an inactive
homologue, SB202474. Similarly, Smad2-speciﬁc siRNA-driven
Smad2 deﬁciency but not negative control siRNA also down-
regulated TIMP-3 induction. Speciﬁc inhibitor of Smad3 (SIS3)
and Smad3 siRNA but not negative control siRNA abolished
TGF-β induction of TIMP-3. Smad2 and -3 siRNAs also down
regulated TIMP-3 promoter-driven luciferase activities, suggest-
ing transcriptional regulation. SiRNA-driven co-Smad4 knock-
down abrogated TIMP-3 augmentation by TGF-β. In contrast,
suppression of inhibitory Smad7 had no effect on TIMP-3 in-
crease. TIMP-3 promoter deletion analysis revealed that -828
deletion retains the original promoter activity while -333 and -167
deletions display somewhat reduced activity.
Conclusions: Receptor-activated Smad2 and Smad3 and co-
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Smad4 critically mediate TGF-β-stimulated TIMP-3 gene expres-
sion in human chondrocytes and TIMP-3 gene is a target of
Smad signaling pathway. Most of the TGF-β-responsive, cis-
acting elements are found in the -167 with additional elements
in upstream fragments.These mechanisms of TIMP-3 regulation
may be pivotal in TGF-β-stimulated cartilage ECM synthesis,
repair and maintenance.
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THE THROMBOSPONDIN-RELATED PROTEIN,
F-SPONDIN, IS EXPRESSED IN EMBRYONIC GROWTH
PLATE CARTILAGE AND CAN ENHANCE THE
EXPRESSION OF CHONDROCYTE MATURATION
MARKERS
G. Palmer, M. Attur, Y. Nemelivsky, A. Piton, H. Al-Mussawir,
S.B. Abramson, C. Teixeira
NYU-Hospital for Joint Diseases, New York, NY
Purpose: We have previously identiﬁed expression of a neuronal
extracellular matrix protein, F-spondin, in cartilage of osteoarthri-
tis (OA) patients. Since OA chondrocytes have been shown
express markers associated with growth plate chondrocyte mat-
uration, we explored whether F-spondin is also expressed in
growth plates during development.
Methods: For cell culture experiments, chondrocytes were iso-
lated from the cephalic portion of 2-week old embryonic chick
sterna. At conﬂuence, cultures were treated with retinoic acid
(RA) to induce maturation, or left unstimulated for 5 days. In
some experiments, F-spondin effects were assessed by plasmid
transfection (GenePorter) or treatment with blocking antibodies.
Chondrocyte maturation was assessed by measurement alkaline
phosphatase (AP) enzyme activity, or semi-quantitative RT-PCR
of chondrogenic markers.
Results: Immunohistochemistry of tibial growth plate cartilage
from 18 day old chick embryos revealed abundant staining for
F-spondin within the hypertrophic and ossifying regions, but no
staining in the immature chondrocytes of the resting and pro-
liferating zones. This expression pattern implicates a role for
F-spondin in late-stage terminal differentiation. To investigate the
role of F-spondin in chondrocyte maturation, we used an in vitro
model in which chick sternal chondrocytes mimic growth plate
chondrocytes and undergo terminal differentiation in response
to RA treatment. RA stimulation for 5 days (10 - 100 nm) re-
sulted in a 2- to 4-fold increase in F-spondin gene expression
when compared to non-stimulated controls. Overexpression of
F-spondin cDNA by plasmid transfection, increased expression
of chondrocyte terminal differentiation markers, MMP-13 (5-fold)
and alkaline phosphatase (AP) (14-fold) in cultures stimulated
with RA (p<0.05). However, this effect was not observed in F-
spondin transfected cultures without RA stimulation, suggesting
that F-spondin acts as an enhancer rather than an inducer of
terminal differentiation. Consistent with these ﬁndings, blocking
F-spondin activity via addition of polyclonal F-spondin antibodies
resulted in an inhibition of RA-induced chondrocyte maturation,
evidenced by decreased AP activity. The level of inhibition was
dependent on the antibody speciﬁcity to F-spondin protein do-
mains; blocking the c-terminal, thrombospondin-like TSR domain
caused a 50% (p<0.01) inhibition of AP activity, while targeting
the n-terminal, spondin domain reduced this effect to 2-10%.
This ﬁnding suggests that F-spondin induction of AP during
chondrocyte maturation is mediated via its TSR domain.
Conclusions: F-spondin is expressed in the developing growth
plate where it acts to enhance terminal differentiation of chondro-
cytes via upregulation of hypertrophic markers. These promat-
uration effects are mediated via novel mechanisms that require
molecular interactions of its protein domains.
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SUSTAINED EFFECTS OF BIOMECHANICAL SIGNALS
ARE MEDIATED VIA PROLONGED INHIBITION OF
I-KAPPA B KINASE ACTIVATION IN ARTICULAR
CHONDROCYTES
S. Madhavan, J. Nam, B. Rath, S. Agarwal
The Ohio State University, Columbus, OH
Purpose: While it is believed that the effects of therapeutic
exercise are sustained for sustained periods of time, te molecular
mechanisms underlying such effects are less understood. Here,
using an in vitro model system, we show that biomechanical
signals suppress inﬂammation for sustained intervals of time and
these effects are mediated by inhibiting NF-κB signaling pathway.
Methods: Articular chondrocytes were harvested from healthy
femur heads of Sprague Dawley rats and used between 2nd and
3rd passages. Dynamic tensile strain (DTF) was applied to chon-
drocytes grown on BioFlex-I® plates using a FX-4000T Flexcell
Int, NC). Cells were subjected to (A) control, (B) IL-1β 1ng/ml
(C) DTF (3% strain at 0.25 Hz), or (D) DTF and IL-1β. Cells
in groups C and D were subjected to DTF at the start of the
experiment, and rHuIL-1β was immediately added to groups B
and D. The cells were subject to DTF for 4, 8, 12, 16, 20 or 24 hr,
followed by a rest period of 20, 16, 12, 8, 4, or 0 h, respectively.
mRNA expression was measured by Real Time PCR. TNF-α
secretion was determined with ELISA kit (R&D Systems). The
nuclear translocation of NF-κB p65 and IκBα was analyzed by
immunoﬂuorescence. Protein expression was analyzed by West-
ern blot analysis using mouse anti-pNF-κB(Ser 536 or Ser 276),
rabbit anti-p65 IgG, rabbit anti-IκBα IgG and rabbit anti-IκBβ IgG.
Kinetics of IKK activation was by a kinase assay using GST-IκBα
and 0.5um ATP. The GST-IκBα on blots was probed with either
anti-phospho-IκBα (Ser32/36) or anti-IκBα.
Results: (1) DTF blocks IL-1β-induced TNFα induction at both
mRNA and protein level in a sustained manner. (2) DTF inhibits
phosphorylation, nuclear translocation, and synthesis of NF-κB
in a sustained manner. DTF also sustained suppression of IL-
1β-induced NF-κB p65 phosphorylation at Ser 536 (Figure 1).
These observations are consistent with the immunoﬂuoresence
analysis shown in Figure 2, where DTF inhibited IL-1β-induced
NF-κB nuclear translocation following exposure to IL-1 and DTF
for 4/20, 8/16, 12/12, 16/8 h of DTF/REST while 20/4 or 24/0h of
DTF/REST did not block NF-κB nuclear translocation completely.
(3) Anti-inﬂammatory effects of DTF are mediated by increased
Figure 1. DTF inhibits IL-1b induced NF-kB phosphorylation.
Figure 2. DTF inhibits IL-1b induced NF-kB nuclear translocation and synthesis.
